IDT combines with 454 in worldwide primer pact
This article was originally published in Clinica
Executive Summary
Roche’s DNA sequencing subsidiary 454 Life Sciences has signed an exclusive co-promotional agreement with nucleic acids specialist Integrated DNA Technologies (IDT). The deal, of which specific financial details were not revealed, will see Coralville, Iowa-based IDT use its online design tool to design, synthesize and purify fusion primers for certain 454 sequencing applications. These applications include sequencing technology for the detection of low-frequency mutations in disease-associated genes, and identification and quantification of common and rare variants within a population.